These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 7622801
1. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression. van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J. Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801 [Abstract] [Full Text] [Related]
3. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED. J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411 [Abstract] [Full Text] [Related]
4. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Smith WT, Glaudin V, Panagides J, Gilvary E. Psychopharmacol Bull; 1990 Aug; 26(2):191-6. PubMed ID: 2236455 [Abstract] [Full Text] [Related]
5. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression. Bremner JD. J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505 [Abstract] [Full Text] [Related]
6. Depressed in-patients respond differently to imipramine and mirtazapine. Bruijn JA, Moleman P, Mulder PG, van den Broek WW. Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374 [Abstract] [Full Text] [Related]
7. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Wade A, Crawford GM, Angus M, Wilson R, Hamilton L. Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891 [Abstract] [Full Text] [Related]
8. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Munizza C, Olivieri L, Di Loreto G, Dionisio P. Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574 [Abstract] [Full Text] [Related]
9. Fluoxetine versus trazodone: efficacy and activating-sedating effects. Beasley CM, Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME. J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559 [Abstract] [Full Text] [Related]
10. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators. Psychosom Med; 2007 Jul; 69(7):606-13. PubMed ID: 17846258 [Abstract] [Full Text] [Related]
11. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home. Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group. Curr Med Res Opin; 2003 Jul; 19(8):737-46. PubMed ID: 14687445 [Abstract] [Full Text] [Related]
12. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G. Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889 [Abstract] [Full Text] [Related]
13. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Malhi GS, Ng F, Berk M. Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778 [Abstract] [Full Text] [Related]
14. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial. Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M. J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165 [Abstract] [Full Text] [Related]
15. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L. Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478 [Abstract] [Full Text] [Related]
16. The effect of mirtazapine in patients with chronic pain and concomitant depression. Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ. Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597 [Abstract] [Full Text] [Related]
17. A comparison of venlafaxine, trazodone, and placebo in major depression. Cunningham LA, Borison RL, Carman JS, Chouinard G, Crowder JE, Diamond BI, Fischer DE, Hearst E. J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464 [Abstract] [Full Text] [Related]
18. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety. Wålinder J, Prochazka J, Odén A, Sjödin I, Dahl ML, Ahlner J, Bengtsson F. Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT. Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799 [Abstract] [Full Text] [Related]
20. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial. Kang EH, Lee IS, Chung SK, Lee SY, Kim EJ, Hong JP, Oh KS, Woo JM, Kim S, Park JE, Yu BH. Psychiatry Res; 2009 Sep 30; 169(2):118-23. PubMed ID: 19695711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]